Methods for preparing thiophene and pyrrole-based heterocyclic compounds are disclosed. Also disclosed are libraries of thiophene and pyrrole-based heterocyclic compounds, methods for preparing the libraries of thiophene and pyrrole-based heterocyclic compounds, and methods for using the thiophene and pyrrole-based heterocyclic compounds and compound libraries of the invention. The compounds of the invention have biological activity including anti-cancer activity.
Claims What is claimed is: 1. A compound represented by the formula (Formula Ia): ##STR21## in which R.sub.2a and R.sub.2b are each, independently, hydrogen, alkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylsulfonyl, or arylsulfonyl; or R.sub.2a and R.sub.2b taken together with the nitrogen atom to which they are attached, form a 3- to 8-membered ring; R.sub.3 is hydrogen, --CN or --C(O)R.sub.6 ; R.sub.4 is alkyl, aralkyl or aryl; R.sub.5 is hydrogen, halogen, alkyl, aryl, or --C(O)R.sub.5' ; and R.sub.5' and R.sub.6 are each independently hydroxyl, alkyl, aryl, alkoxy, aryloxy, --SH, alkylthio, arylthio, amino, or a linker to a solid support; or a salt thereof, with the proviso that R.sub.2a and R.sub.2b are not hydrogen simultaneously. 2. The compound of claim 1, wherein R.sub.2b is arylcarbonyl. 3. The compound of claim 1, wherein R.sub.6 is hydroxy. 4. The compound of claim 1, wherein R.sub.6 is a linker to a solid support. 5. The compound of claim 1, wherein R.sub.4 is methyl. 6. The compound of claim 1, wherein R.sub.5, is amino. 7. A compound represented by the formula (Formula Ib): ##STR22## in which R.sub.4 is alkyl; R.sub.7 is hydrogen alkyl; orcycloalky R.sub.8 is aryl; and R.sub.9 is alkyl or aryl; or a salt thereof. 8. The compound of claim 7, in which R.sub.7 is cyclopropyl. 9. The compound of claim 7, in which R.sub.9 is substituted or unsubstituted phenyl. 10. A method for preparing a compound represented by the formula (Formula Ia): ##STR23## in which R.sub.2a and R.sub.2b are each, independently hydrogen, alkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylsulfonyl, or arylsulfonyl; or R.sub.2a and R.sub.2b taken together with the nitrogen atom to which they are attached, form a 3to 8-membered ring; R.sub.3 is hydrogen, --CN or --C(O)R.sub.6 ; R.sub.4 is alkyl, aralkyl or aryl; R.sub.5 is hydrogen, halogen, alkyl, aryl, or --C(O)R.sub.5' ; and R.sub.5' and R.sub.6 are each independently hydroxyl, alkyl, aryl, alkoxy, aryloxy, --SH, alkylthio, arylthio, amino, or a linker to a solid support; or a salt thereof; the method comprising the step of reacting a first compound represented by the formula R.sub.4 C(O)CH.sub.2 R.sub.5 with a compound represented by the formula R.sub.6 C(O)CH.sub.2 CN, and with elemental sulfur, in the presence of a pyridine compound, such that a compound of Formula Ia is prepared. 11. The method of claim 10, in which R.sub.3 is --C(O)R.sub.6. 12. The method of claim 11, in which at least about 1-2 moles of sulfur are used for each mole of R.sub.4 C(O)CH.sub.2 R.sub.5. 13. The method of claim 11, in which the compound represented by the formula R.sub.6 C(O)CH.sub.2 CN is t-butylcyanoacetate. 14. The method of claim 11, in which R.sub.2a is hydrogen. 15. The method of claim 11, in which at least one of R.sub.5', and R.sub.6 is a linker to a solid support, and the compound of Formula Ia is prepared by solid-phase synthesis. 16. The method of claim 11, in which the method includes the further step of purifying the compound of Formula Ia. 17. The method of claim 11, in which the reaction is performed in a solvent comprising pyridine. 18. The method of claim 17, in which the solvent comprises at least about 50% pyridine. 19. A library of compounds as claimed in claim 1, wherein the library comprises a multiplicity of compounds represented by the formula (Formula Ia). 20. The library of claim 19, in which the library comprises at least 30 different compounds. 21. The method of claim 10, wherein at least one of said first and second compounds is provided as a variegated population such that a library of compounds of Formula Ia is prepared. 22. A method for inhibiting unwanted cell growth in a subject, the method comprising: administering to the subject an effective amount of a compound represented by the formula (Formula Ia): ##STR24## in which R.sub.2a and R.sub.2b are each, independently selected from the group consisting of hydrogen, alkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylsulfonyl, or arylsulfonyl; or R.sub.2a and R.sub.2b taken together with the nitrogen atom to which they are attached, form a 3- or 8-membered ring; R.sub.3 is hydrogen, --CN or --C(O)R.sub.6 ; R.sub.4 is alkyl, aralkyl or aryl; R.sub.5 is hydrogen, halogen, alkyl, aryl, or --C(O)R.sub.5' ; and R.sub.5' and R.sub.6 are each independently selected from the group consisting of hydroxy, alkyl, aryl, alkoxy, aryloxy, --SH, alkylthio, arylthio, amino, or a salt thereof; such that unwanted cell growth is inhibited in the subject. 23. The method of claim 22, in which the unwanted cell growth is due to lung cancer. 24. The method of claim 22, wherein said compound of Formula Ia is represented by the formula (Formula Ib): ##STR25## in which R.sub.4' is alkyl; R.sub.7 is hydrogen or alkyl; R.sub.8 is aryl; and R.sub.9 is alkyl or aryl; or a salt thereof. 25. A pharmaceutical composition comprising a compound of claim 1 in a pharmaceutically-acceptable carrier. 26. A compound represented by the formula (Formula Ia): ##STR26## in which R.sub.2a is hydrogen, alkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylsulfonyl, or arylsulfonyl; R.sub.2b is arylcarbonyl; R.sub.3 is hydrogen, --CN or --C(O)R.sub.6 ; R.sub.4 is alkyl, aralkyl or aryl; R.sub.5 is hydrogen, halogen, alkyl, aryl, or --C(O)R.sub.5' ; and R.sub.5' and R.sub.6 are each independently hydroxyl, alkyl, aryl, alkoxy, aryloxy, --SH, alkylthio, arylthio, amino, or a linker to a solid support; or a salt thereof. 27. A library of compounds as claimed in claim 1, wherein said library comprises a multiplicity of compounds represented by the Formula Ia, said library having been prepared by the method comprising: reacting a first compound represented by the formula R.sub.4 C(O)CH.sub.2 R.sub.5 with a second compound represented by the formula R.sub.6 C(O)CH.sub.2 CN, and with elemental sulfur, in the presence of a pyridine compound, in which at least one of said first and second compounds is provided as a variegated population, such that a library of compounds of Formula Ia is prepared. 28. A method for preparing a library of compounds represented by the formula (Formula Ia): ##STR27## in which R.sub.2a and R.sub.2b are each, independently hydrogen, alkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylsulfonyl, or arylsulfonyl; or R.sub.2a and R.sub.2b taken together with the nitrogen atom to which they are attached, form a 3to 8-membered ring; R.sub.3 is hydrogen, --CN or --C(O)R.sub.6 ; R.sub.4 is alkyl, aralkyl or aryl; R.sub.5 is hydrogen, halogen, alkyl, aryl, or --C(O)R.sub.5' ; and R.sub.5' and R.sub.6 are each independently hydroxyl, alkyl, aryl, alkoxy, aryloxy, --SH, alkylthio, arylthio, amino, or a linker to a solid support; or a salt thereof; the method comprising the step of reacting a first compound represented by the formula R.sub.4 C(O)CH.sub.2 R.sub.5 with a second compound represented by the formula R.sub.6 C(O)CH.sub.2 CN, and with elemental sulfur, in the presence of a pyridine compound, wherein at least one of said first and second compounds is provided as a variegated population such that a library of compounds of Formula Ia is prepared. 29. The compound of claim 1 represented by the formula (Formula Id): ##STR28## in which R.sub.2a is optionally substituted arylsulfonyl or optionally substituted arylcarbonyl; R.sub.5' is hydroxy or alkoxy; R.sub.6 is alkoxy; or a salt thereof. 30. The compound of claim 29 wherein R.sub.2a is a substituted arylsulfonyl. 31. The compound of claim 30 wherein the aryl moiety of said arylsulfonyl is disubstituted with halogen. 32. The compound of claim 31 wherein the halogen is chlorine. 33. The compound of claim 30 wherein the aryl moiety of said arylsulfonyl is disubstituted with trifluoromethyl. 34. The compound of claim 29 wherein R.sub.2a is a monosubstituted arylsulfonyl. 35. The compound of claim 34 wherein the aryl moiety of said arylsulfonyl is monosubstituted with halogen. 36. The compound of claim 35 wherein the halogen is chlorine. 37. The compound of claim 30 wherein R.sub.5' and R.sub.6 are ethoxy. 38. The compound of claim 30 wherein R.sub.5' is hydroxy and R.sub.6 is ethoxy. 39. The compound of claim 30 wherein R.sub.5' and R.sub.6 are isopropoxy. 40. The compound of claim 34 wherein R.sub.5' and R.sub.6 are ethoxy. 41. The compound of claim 33 wherein R.sub.5' and R.sub.6 are ethoxy. 42. The compound of claim 29 wherein R.sub.2a is a substituted arylcarbonyl. 43. The compound of claim 42 wherein the aryl moiety of said arylcarbonyl is disubstituted with halogen. 44. The compound of claim 43 wherein the halogen is chlorine. 45. The compound of claim 42 wherein R.sub.5' and R.sub.6 are ethoxy. 46. The compound of claim 29 wherein R.sub.2a is substituted arylsulfonyl, R.sub.5' is hydroxy or alkoxy, and R.sub.6 is alkoxy. 47. The compound of claim 46 wherein R.sub.2a is phenylsulfonyl, the phenyl moiety of which is disubstituted with chlorine. 48. The compound of claim 47 wherein R.sub.5' and R.sub.6 are ethoxy. 49. The compound of claim 47 wherein R.sub.5' is hydroxy and R.sub.6 is ethoxy. 50. The compound of claim 47 wherein R.sub.5' and R.sub.6 are isopropoxy. 51. The compound of claim 46 wherein R.sub.2a is phenylsulfonyl, the phenyl moiety of which is disubstituted with trifluoromethyl. 52. The compound of claim 51 wherein R.sub.5' and R.sub.6 are ethoxy. 53. The compound of claim 29 wherein R.sub.2a is monosubstituted arylsulfonyl and R.sub.5' and R.sub.6 are alkoxy. 54. The compound of claim 33 wherein R.sub.2a is phenylsulfonyl, the phenyl moiety of which is monosubstituted by chlorine. 55. The compound of claim 54 wherein R.sub.5' and R.sub.6 are ethoxy. 56. The compound of claim 29 wherein R.sub.2a is substituted arylcarbonyl and R.sub.5' and R.sub.6 are alkoxy. 57. The compound of claim 56 wherein R.sub.2a is phenylcarbonyl, the phenyl moiety of which is disubstituted by chlorine. 58. The compound of claim 57 wherein R.sub.5' and R.sub.6 are ethoxy. 59. The sodium salt of the compound of claim 48. 60. The sodium salt of the compound of claim 50. 61. The method of claim 22, wherein said compound of Formula Ia is represented by the formula (Formula Id): ##STR29## in which R.sub.2a is arylsulfonyl or arylcarbonyl; R.sub.5' is hydroxy or alkoxy; R.sub.6 is alkoxy; or a salt thereof. 62. The method of claims 10 or 28 wherein said pyridine compound is selected from the group consisting of pyridine, substituted pyridines, lutidine, 2,6,-di-t -butylpyridine, fused pyridines, and quinoline. 63. The method of claim 62 wherein said pyridine compound is pyridine. 64. A pharmaceutical composition comprising a compound of claims 7, 26 or 29 and a pharmaceutically-acceptable carrier. 